This is a review about B2M, based on 7 published articles (read how Labome selects the articles), using B2M antibody in all methods. It is aimed to help Labome visitors find the most suited B2M antibody.
B2M synonym: IMD43; beta chain of MHC class I molecules; beta-2-microglobin

Abcam
rabbit polyclonal
  • IHC-F; mouse
Abcam B2M antibody (Abcam, Ab87483) was used in immunohistochemistry - frozen section on mouse samples. Transplant Res (2013) ncbi
mouse monoclonal (B2M-01)
  • Neut; human; 25 ug/mL
Abcam B2M antibody (Abcam, ab21899) was used in neutralization on human samples at 25 ug/mL. Methods (2013) ncbi
Invitrogen
mouse monoclonal (B2M-01)
  • FC; equine; fig 1
In order to study MHC class I-restricted, virus-specific CTL responses in horses, Invitrogen B2M antibody (Caltag, B2M-01) was used in flow cytometry on equine samples (fig 1). J Immunol (2003) ncbi
Santa Cruz Biotechnology
not indicated
  • WB; human
Santa Cruz Biotechnology B2M antibody was used in western blot to study the association of ILT2 and murine MHC class I molecules in vivo.Eur J Immunol (2006) ncbi
Individual Researcher
not indicated
  • IHC; human
Dr. Soldano Ferrone (Roswell Park Cancer Institute) anti-beta 2 m mAb NAMB-1 antibody was used in immunohistochemistry to study the complete loss of HLA class I expression in melanoma cellsClin Cancer Res (2006) ncbi
Dako
not indicated
  • IHC; human
Dako anti-B2m was used to perform immunohistochemistry in order to study the presence of specific populations of tumor infiltrating lymphocytes in diagnostic primary melanoma biopsies are associated with outcome in clinically stage II melanoma patients.Int J Cancer (2008) ncbi
not indicated
  • IHC; human
DakoCytomation anti HMB-45 antigen mAb was used in immunohistochemistry to study the complete loss of HLA class I expression in melanoma cellsClin Cancer Res (2006) ncbi
others
not indicatedScripps Laboratories human beta2-microglubulin was used in binding assays in order to investigate the correlations between approaches used for epitope discovery: ELISPOT assays, binding assays, and prediction software.Virology (2008) ncbi
Articles Reviewed
  1. Stefan M Brunner et al. (2013). "IL-13 signaling via IL-13Ralpha2 triggers TGF-beta1-dependent allograft fibrosis".PMID 24143891
  2. Huaying Zhao et al. (2013). "A comparison of binding surfaces for SPR biosensing using an antibody-antigen system and affinity distribution analysis".PMID 23270815
  3. Milton Maciel et al. (2008). "Comprehensive analysis of T cell epitope discovery strategies using 17DD yellow fever virus structural proteins and BALB/c (H2d) mice model".PMID 18579176
  4. Inge S van Houdt et al. (2008). "Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression".PMID 18498132
  5. Siyuan Liang et al. (2006). "Human ILT2 receptor associates with murine MHC class I molecules in vivo and impairs T cell function".PMID 16897816
  6. Annette Paschen et al. (2006). "The coincidence of chromosome 15 aberrations and beta2-microglobulin gene mutations is causative for the total loss of human leukocyte antigen class I expression in melanoma".PMID 16740750
  7. Travis C McGuire et al. (2003). "Presentation and binding affinity of equine infectious anemia virus CTL envelope and matrix protein epitopes by an expressed equine classical MHC class I molecule".PMID 12902502